Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Original article

Vol. 154 No. 9 (2024)

Behavioural patterns and dangers: a mixed-methods exploration of simultaneous polysubstance use and intervention strategies among Swiss adolescents

DOI
https://doi.org/10.57187/s.3895
Cite this as:
Swiss Med Wkly. 2024;154:3895
Published
13.09.2024

Summary

BACKGROUND: Recent trends in Switzerland indicate a concerning rise in simultaneous polysubstance use among adolescents, a practice marked by the concurrent or sequential consumption of multiple psychoactive substances, notably alcohol and cannabis, alongside prescription medications (e.g. benzodiazepines) and illicit drugs, resulting in dozens of fatal outcomes. However, data on simultaneous polysubstance use and evidence-based approaches to effective prevention is lacking.

AIMS OF THE STUDY: The study aimed to explore and gain insights into use patterns, use settings, use motives, harm-reduction strategies, concerns associated with substance use, and support and counselling services from the point of view of adolescents practicing simultaneous polysubstance use in Switzerland.

METHODS: An exploratory study was conducted via an online survey (n = 116) and two focus group discussions with affected Swiss adolescents aged 14 to 20. A mixed-methods approach was applied to gain insights and better understand the phenomenon of simultaneous polysubstance use among Swiss adolescents. Quantitative survey data obtained between November 2021 and March 2023 by means of convenience sampling – organised by distributing flyers (in three national languages) among several project partners, on the internet, over social media and by word of mouth – was analysed descriptively, whereas qualitative survey data and focus group data were thematically explored. A concurrent nested design was employed, utilising quantitative findings as a core foundation for addressing research questions, while qualitative findings were instrumental in validating and providing contextual depth to the results.

RESULTS: Our findings reveal a preference of the sample for combining alcohol with cannabis and/or other substances (e.g. benzodiazepines or hard drugs) in social settings, driven by diverse motives, including enhancement of experiences and partly maladaptive coping mechanisms leading to self-medication. Despite some awareness of the potential harms, there is a significant reliance on peer-shared strategies for harm reduction, highlighting a gap in formal support and counselling services, some of which are perceived by adolescents as lacking empathy and relevance.

CONCLUSIONS: This study underscores the urgency of developing targeted, youth-centred interventions that resonate with the lived realities of adolescents, aiming not only to reduce substance use but also to address the broader psychosocial factors contributing to simultaneous polysubstance use. By shedding light on the complex dynamics of adolescent polysubstance use, our research contributes to the ongoing dialogue on effective prevention strategies, advocating for a holistic approach encompassing education, policy reform and community support to tackle this multifaceted public health challenge.

References

  1. Day C. Benzodiazepines in Combination with Opioid Pain Relievers or Alcohol: Greater Risk of More Serious ED Visit Outcomes. 2014 Dec 18. The CBHSQ Report. Rockville (MD). US: Substance Abuse and Mental Health Services Administration; 2013., Available from https://www.ncbi.nlm.nih.gov/books/NBK384672/
  2. Ibañez GE, Levi-Minzi MA, Rigg KK, Mooss AD. Diversion of benzodiazepines through healthcare sources. J Psychoactive Drugs. 2013;45(1):48–56. doi: https://doi.org/10.1080/02791072.2013.764232 DOI: https://doi.org/10.1080/02791072.2013.764232
  3. McCabe SE, Boyd CJ, Young A. Medical and nonmedical use of prescription drugs among secondary school students. J Adolesc Health. 2007 Jan;40(1):76–83. doi: https://doi.org/10.1016/j.jadohealth.2006.07.016 DOI: https://doi.org/10.1016/j.jadohealth.2006.07.016
  4. Peters RJ Jr, Meshack AF, Kelder SH, Webb P, Smith D, Garner K. Alprazolam (Xanax) use among southern youth: beliefs and social norms concerning dangerous rides on “handlebars”. J Drug Educ. 2007;37(4):417–28. doi: https://doi.org/10.2190/DE.37.4.e DOI: https://doi.org/10.2190/DE.37.4.e
  5. Mateu-Gelabert P, Jessell L, Goodbody E, Kim D, Gile K, Teubl J, et al. High enhancer, downer, withdrawal helper: multifunctional nonmedical benzodiazepine use among young adult opioid users in New York City. Int J Drug Policy. 2017 Aug;46:17–27. doi: https://doi.org/10.1016/j.drugpo.2017.05.016 DOI: https://doi.org/10.1016/j.drugpo.2017.05.016
  6. Kurtz SP, Buttram ME, Surratt HL. Benzodiazepine Dependence among Young Adult Participants in the Club Scene Who Use Drugs. J Psychoactive Drugs. 2017;49(1):39–46. doi: https://doi.org/10.1080/02791072.2016.1269978 DOI: https://doi.org/10.1080/02791072.2016.1269978
  7. Marshall BD, Green TC, Elston B, Yedinak JL, Hadland SE, Clark MA. The Effectiveness of Internet- and Field-Based Methods to Recruit Young Adults Who Use Prescription Opioids Nonmedically. Subst Use Misuse. 2018 Aug;53(10):1688–99. doi: https://doi.org/10.1080/10826084.2018.1425725 DOI: https://doi.org/10.1080/10826084.2018.1425725
  8. Kelly BC, Vuolo M. Social network ties to nightlife and healthcare professionals and prescription drug misuse among young adults. Int J Drug Policy. 2019 Apr;66:48–56. doi: https://doi.org/10.1016/j.drugpo.2019.01.007 DOI: https://doi.org/10.1016/j.drugpo.2019.01.007
  9. Maust DT, Lin LA, Blow FC. Benzodiazepine Use and Misuse Among Adults in the United States. Psychiatr Serv. 2019 Feb;70(2):97–106. doi: https://doi.org/10.1176/appi.ps.201800321 DOI: https://doi.org/10.1176/appi.ps.201800321
  10. Hemels ME, Koren G, Einarson TR. Increased use of antidepressants in Canada: 1981-2000. Ann Pharmacother. 2002 Sep;36(9):1375–9. doi: https://doi.org/10.1345/aph.1A331 DOI: https://doi.org/10.1345/aph.1A331
  11. Gu Q, Dillon CF, Burt VL. Prescription Drug Use Continues to Increase: U.S. Prescription Drug Da ta for 2007-2008. American Psychological Association. APA; 2010. DOI: https://doi.org/10.1037/e665492010-001
  12. Bachhuber MA, Hennessy S, Cunningham CO, Starrels JL. Increasing Benzodiazepine Prescriptions and Overdose Mortality in the United States, 1996-2013. Am J Public Health. 2016 Apr;106(4):686–8. doi: https://doi.org/10.2105/AJPH.2016.303061 DOI: https://doi.org/10.2105/AJPH.2016.303061
  13. Ghosh A, Simon K, Sommers BD. The Effect of Health Insurance on Prescription Drug Use Among Low-Income Adults:Evidence from Recent Medicaid Expansions. J Health Econ. 2019 Jan;63:64–80. doi: https://doi.org/10.1016/j.jhealeco.2018.11.002 DOI: https://doi.org/10.1016/j.jhealeco.2018.11.002
  14. Votaw VR, Geyer R, Rieselbach MM, McHugh RK. The epidemiology of benzodiazepine misuse: A systematic review. Drug Alcohol Depend. 2019 Jul;200:95–114. doi: https://doi.org/10.1016/j.drugalcdep.2019.02.033 DOI: https://doi.org/10.1016/j.drugalcdep.2019.02.033
  15. McCabe SE, West BT. Medical and nonmedical use of prescription benzodiazepine anxiolytics among U.S. high school seniors. Addict Behav. 2014 May;39(5):959–64. doi: https://doi.org/10.1016/j.addbeh.2014.01.009 DOI: https://doi.org/10.1016/j.addbeh.2014.01.009
  16. Schepis TS, Krishnan-Sarin S. Characterizing adolescent prescription misusers: a population-based study. J Am Acad Child Adolesc Psychiatry. 2008 Jul;47(7):745–54. doi: https://doi.org/10.1097/CHI.0b013e318172ef0d DOI: https://doi.org/10.1097/CHI.0b013e318172ef0ld
  17. McCabe SE, West BT, Cranford JA, Ross-Durow P, Young A, Teter CJ, et al. Medical misuse of controlled medications among adolescents. Arch Pediatr Adolesc Med. 2011 Aug;165(8):729–35. doi: https://doi.org/10.1001/archpediatrics.2011.114 DOI: https://doi.org/10.1001/archpediatrics.2011.114
  18. Ford JA, Watkins WC. Adolescent nonmedical prescription drug use. Prev Res. 2012;19(1):3–7. DOI: https://doi.org/10.1037/e542612012-002
  19. Murphy KD, Byrne S, McCarthy S, Lambert S, Sahm LJ. Benzodiazepine use among young attendees of an Irish substance treatment center. J Addict Med. 2014;8(3):199–204. doi: https://doi.org/10.1097/ADM.0000000000000025 DOI: https://doi.org/10.1097/ADM.0000000000000025
  20. Fotiou A, Kanavou E, Richardson C, Kokkevi A. Trends in the association between prescribed and non-prescribed use of tranquillisers or sedatives among adolescents in 22 European countries. Nord Alkohol- Narkotikatidskrift. 2014;31(4):371–87. doi: https://doi.org/10.2478/nsad-2014-0029 DOI: https://doi.org/10.2478/nsad-2014-0029
  21. Lim JK, Earlywine JJ, Bagley SM, Marshall BD, Hadland SE. Polysubstance Involvement in Opioid Overdose Deaths in Adolescents and Young Adults, 1999-2018. JAMA Pediatr. 2021 Feb;175(2):194–6. doi: https://doi.org/10.1001/jamapediatrics.2020.5035 DOI: https://doi.org/10.1001/jamapediatrics.2020.5035
  22. Zervos AP, Hensel DJ, James R, Hunt A, Ott MA. The role of trauma and positive youth development in polysubstance use among rural middle school students: a latent class analysis. BMC Public Health. 2022 Dec;22(1):2350. doi: https://doi.org/10.1186/s12889-022-14795-1 DOI: https://doi.org/10.1186/s12889-022-14795-1
  23. Schepis TS, Klare DL, Ford JA, McCabe SE. Prescription Drug Misuse: Taking a Lifespan Perspective. Subst Abuse. 2020 Mar;14:1178221820909352. doi: https://doi.org/10.1177/1178221820909352 DOI: https://doi.org/10.1177/1178221820909352
  24. Schmitz A. Benzodiazepine use, misuse, and abuse: A review. Ment Health Clin. 2016 May;6(3):120–6. doi: https://doi.org/10.9740/mhc.2016.05.120 DOI: https://doi.org/10.9740/mhc.2016.05.120
  25. WHO. Global status report on alcohol and health 2018. World Health Organization; 2019.
  26. Mayberry S, Nechuta S, Krishnaswami S. Impact of benzodiazepines and polysubstance status on repeat non-fatal drug overdoses. J Subst Abuse Treat. 2021 Apr;123:108285. doi: https://doi.org/10.1016/j.jsat.2021.108285 DOI: https://doi.org/10.1016/j.jsat.2021.108285
  27. Ford JA, Schepis TS, McCabe SE. Poly-prescription drug misuse across the life course: prevalence and correlates across different adult age cohorts in the U.S. Int J Drug Policy. 2021 Feb;88:103017. doi: https://doi.org/10.1016/j.drugpo.2020.103017 DOI: https://doi.org/10.1016/j.drugpo.2020.103017
  28. Jones JD, Mogali S, Comer SD. Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend. 2012 Sep;125(1-2):8–18. doi: https://doi.org/10.1016/j.drugalcdep.2012.07.004 DOI: https://doi.org/10.1016/j.drugalcdep.2012.07.004
  29. Compton WM, Valentino RJ, DuPont RL. Polysubstance use in the U.S. opioid crisis. Mol Psychiatry. 2021 Jan;26(1):41–50. doi: https://doi.org/10.1038/s41380-020-00949-3 DOI: https://doi.org/10.1038/s41380-020-00949-3
  30. Karamouzian M, Pilarinos A, Hayashi K, Buxton JA, Kerr T. Latent patterns of polysubstance use among people who use opioids: A systematic review. Int J Drug Policy. 2022 Apr;102:103584. doi: https://doi.org/10.1016/j.drugpo.2022.103584 DOI: https://doi.org/10.1016/j.drugpo.2022.103584
  31. Lyons RM, Yule AM, Schiff D, Bagley SM, Wilens TE. Risk Factors for Drug Overdose in Young People: A Systematic Review of the Literature. J Child Adolesc Psychopharmacol. 2019 Aug;29(7):487–97. doi: https://doi.org/10.1089/cap.2019.0013 DOI: https://doi.org/10.1089/cap.2019.0013
  32. Schneider KE, Park JN, Allen ST, Weir BW, Sherman SG. Patterns of polysubstance use and overdose among people who inject drugs in Baltimore, Maryland: A latent class analysis. Drug Alcohol Depend. 2019 Aug;201:71–7. doi: https://doi.org/10.1016/j.drugalcdep.2019.03.026 DOI: https://doi.org/10.1016/j.drugalcdep.2019.03.026
  33. Williams GC, Patte KA, Ferro MA, Leatherdale ST. Substance use classes and symptoms of anxiety and depression among Canadian secondary school students. Health Promot Chronic Dis Prev Can. 2021 May;41(5):153–64. doi: https://doi.org/10.24095/hpcdp.41.5.02 DOI: https://doi.org/10.24095/hpcdp.41.5.02
  34. Rodríguez-Cano R, Kypriotakis G, Cortés-García L, Bakken A, von Soest T. Polysubstance use and its correlation with psychosocial and health risk behaviours among more than 95,000 Norwegian adolescents during the COVID-19 pandemic (January to May 2021): a latent profile analysis. Lancet Reg Health Eur. 2023 May;28:100603. doi: https://doi.org/10.1016/j.lanepe.2023.100603 DOI: https://doi.org/10.1016/j.lanepe.2023.100603
  35. Lanza HI, Bello MS, Cho J, Barrington-Trimis JL, McConnell R, Braymiller JL, et al. Tobacco and cannabis poly-substance and poly-product use trajectories across adolescence and young adulthood. Prev Med. 2021 Jul;148:106545. doi: https://doi.org/10.1016/j.ypmed.2021.106545 DOI: https://doi.org/10.1016/j.ypmed.2021.106545
  36. Quek LH, Chan GC, White A, Connor JP, Baker PJ, Saunders JB, et al. Concurrent and simultaneous polydrug use: latent class analysis of an Australian nationally representative sample of young adults. Front Public Health. 2013 Nov;1:61. doi: https://doi.org/10.3389/fpubh.2013.00061 DOI: https://doi.org/10.3389/fpubh.2013.00061
  37. Chan G, Connor J, Hall W, Leung J. The changing patterns and correlates of population-level polysubstance use in Australian youth: a multi-group latent class analysis of nationally representative samples spanning 12 years. Addiction. 2020 Jan;115(1):145–55. doi: https://doi.org/10.1111/add.14761 DOI: https://doi.org/10.1111/add.14761
  38. Kelly AB, Chan GC, White A, Saunders JB, Baker PJ, Connor JP. Is there any evidence of changes in patterns of concurrent drug use among young Australians 18-29 years between 2007 and 2010? Addict Behav. 2014 Aug;39(8):1249–52. doi: https://doi.org/10.1016/j.addbeh.2014.04.009 DOI: https://doi.org/10.1016/j.addbeh.2014.04.009
  39. Silveira ML, Green VR, Iannaccone R, Kimmel HL, Conway KP. Patterns and correlates of polysubstance use among US youth aged 15-17 years: wave 1 of the Population Assessment of Tobacco and Health (PATH) Study. Addiction. 2019 May;114(5):907–16. doi: https://doi.org/10.1111/add.14547 DOI: https://doi.org/10.1111/add.14547
  40. Fahey KM, Kovacek K, Abramovich A, Dermody SS. Substance use prevalence, patterns, and correlates in transgender and gender diverse youth: A scoping review. Drug Alcohol Depend. 2023 Sep;250:110880. doi: https://doi.org/10.1016/j.drugalcdep.2023.110880 DOI: https://doi.org/10.1016/j.drugalcdep.2023.110880
  41. Oldham M, Livingston M, Whitaker V, Callinan S, Fairbrother H, Curtis P, et al. Trends in the psychosocial characteristics of 11-15-year-olds who still drink, smoke, take drugs and engage in poly-substance use in England. Drug Alcohol Rev. 2021 May;40(4):597–606. doi: https://doi.org/10.1111/dar.13201 DOI: https://doi.org/10.1111/dar.13201
  42. Horváth Z, Király O, Demetrovics Z, Németh Á, Várnai D, Urbán R. Polysubstance Use Is Positively Associated with Gaming Disorder Symptom Severity: A Latent Class Analytical Study. Eur Addict Res. 2022;28(1):12–22. doi: https://doi.org/10.1159/000517042 DOI: https://doi.org/10.1159/000517042
  43. Haider MR, Jayawardhana J. Opioid and benzodiazepine misuse in the United States: the impact of socio-demographic characteristics. Am J Addict. 2024 Jan;33(1):71–82. doi: https://doi.org/10.1111/ajad.13481 DOI: https://doi.org/10.1111/ajad.13481
  44. Kidd JD, Jackman KB, Wolff M, Veldhuis CB, Hughes TL. Risk and Protective Factors for Substance Use among Sexual and Gender Minority Youth: A Scoping Review. Curr Addict Rep. 2018 Jun;5(2):158–73. doi: https://doi.org/10.1007/s40429-018-0196-9 DOI: https://doi.org/10.1007/s40429-018-0196-9
  45. Spooner C, Mattick RP, Noffs W. A study of the patterns and correlates of substance use among adolescents applying for drug treatment. Aust N Z J Public Health. 2000 Oct;24(5):492–502. doi: https://doi.org/10.1111/j.1467-842X.2000.tb00499.x DOI: https://doi.org/10.1111/j.1467-842X.2000.tb00499.x
  46. Evans BE, Kim Y, Hagquist C. A latent class analysis of changes in adolescent substance use between 1988 and 2011 in Sweden: associations with sex and psychosomatic problems. Addiction. 2020 Oct;115(10):1932–41. doi: https://doi.org/10.1111/add.15040 DOI: https://doi.org/10.1111/add.15040
  47. Coulter RW, Ware D, Fish JN, Plankey MW. Latent Classes of Polysubstance Use Among Adolescents in the United States: Intersections of Sexual Identity with Sex, Age, and Race/Ethnicity. LGBT Health. 2019 Apr;6(3):116–25. doi: https://doi.org/10.1089/lgbt.2018.0149 DOI: https://doi.org/10.1089/lgbt.2018.0149
  48. Baiden P, Onyeaka HK, Aneni K, Wood B, LaBrenz CA, Muoghalu C, et al. Perceived racial discrimination and polysubstance use among racial/ethnic minority adolescents in the United States. Drug Alcohol Depend. 2023 Jul;248:109894. doi: https://doi.org/10.1016/j.drugalcdep.2023.109894 DOI: https://doi.org/10.1016/j.drugalcdep.2023.109894
  49. Florimbio AR, Coughlin LN, Bauermeister JA, Young SD, Zimmerman MA, Walton MA, et al. Risky Drinking in Adolescents and Emerging Adults: Differences between Individuals Using Alcohol Only versus Polysubstances. Subst Use Misuse. 2023;58(2):211–20. doi: https://doi.org/10.1080/10826084.2022.2152192 DOI: https://doi.org/10.1080/10826084.2022.2152192
  50. Pergolizzi J, Breve F, Magnusson P, LeQuang JA, Varrassi G. Cocaethylene: When Cocaine and Alcohol Are Taken Together. Cureus. 2022 Feb;14(2):e22498. doi: https://doi.org/10.7759/cureus.22498 DOI: https://doi.org/10.7759/cureus.22498
  51. Farooq MU, Bhatt A, Patel M. Neurotoxic and cardiotoxic effects of cocaine and ethanol. J Med Toxicol. 2009 Sep;5(3):134–8. doi: https://doi.org/10.1007/BF03161224 DOI: https://doi.org/10.1007/BF03161224
  52. Drugs EMCf. Health and social responses to drug problems: a European guide. Publications office of the European Union; 2017. Report No.: 9294971961.
  53. Votaw VR, McHugh RK, Vowles KE, Witkiewitz K. Patterns of Polysubstance Use among Adults with Tranquilizer Misuse. Subst Use Misuse. 2020;55(6):861–70. doi: https://doi.org/10.1080/10826084.2019.1708118 DOI: https://doi.org/10.1080/10826084.2019.1708118
  54. Oldenhof E, Anderson-Wurf J, Hall K, Staiger PK. Beyond Prescriptions Monitoring Programs: The Importance of Having the Conversation about Benzodiazepine Use. J Clin Med. 2019 Dec;8(12):2143. doi: https://doi.org/10.3390/jcm8122143 DOI: https://doi.org/10.3390/jcm8122143
  55. Figgatt MC, Austin AE, Cox ME, Proescholdbell S, Marshall SW, Naumann RB. Trends in unintentional polysubstance overdose deaths and individual and community correlates of polysubstance overdose, North Carolina, 2009-2018. Drug Alcohol Depend. 2021 Feb;219:108504. doi: https://doi.org/10.1016/j.drugalcdep.2020.108504 DOI: https://doi.org/10.1016/j.drugalcdep.2020.108504
  56. Wightman RS, Perrone J, Scagos R, Krieger M, Nelson LS, Marshall BD. Opioid Overdose Deaths with Buprenorphine Detected in Postmortem Toxicology: a Retrospective Analysis. J Med Toxicol. 2021 Jan;17(1):10–5. doi: https://doi.org/10.1007/s13181-020-00795-3 DOI: https://doi.org/10.1007/s13181-020-00795-3
  57. Toledo-Fernández A, Marín-Navarrete R, Villalobos-Gallegos L, Salvador-Cruz J, Benjet C, Roncero C. Exploring the prevalence of substance-induced neurocognitive disorder among polysubstance users, adding subjective and objective evidence of cognitive impairment. Psychiatry Res. 2020 Jun;288:112944. doi: https://doi.org/10.1016/j.psychres.2020.112944 DOI: https://doi.org/10.1016/j.psychres.2020.112944
  58. Banks DE, Hershberger AR, Pemberton T, Clifton RL, Aalsma MC, Zapolski TC. Poly-use of cannabis and other substances among juvenile-justice involved youth: variations in psychological and substance-related problems by typology. Am J Drug Alcohol Abuse. 2019;45(3):313–22. doi: https://doi.org/10.1080/00952990.2018.1558450 DOI: https://doi.org/10.1080/00952990.2018.1558450
  59. Gudin JA, Mogali S, Jones JD, Comer SD. Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use. Postgrad Med. 2013 Jul;125(4):115–30. doi: https://doi.org/10.3810/pgm.2013.07.2684 DOI: https://doi.org/10.3810/pgm.2013.07.2684
  60. Stamates AL, Roberts R, Lau-Barraco C. Alcohol, cannabis, and tobacco polysubstance use: A latent profile analysis of age of onset. Subst Abus. 2022;43(1):531–8. doi: https://doi.org/10.1080/08897077.2021.1949777 DOI: https://doi.org/10.1080/08897077.2021.1949777
  61. Palamar JJ, Le A, Mateu-Gelabert P. Not just heroin: extensive polysubstance use among US high school seniors who currently use heroin. Drug Alcohol Depend. 2018 Jul;188:377–84. doi: https://doi.org/10.1016/j.drugalcdep.2018.05.001 DOI: https://doi.org/10.1016/j.drugalcdep.2018.05.001
  62. Carbonneau R, Vitaro F, Brendgen M, Tremblay RE. Longitudinal patterns of polysubstance use throughout adolescence: association with adult substance use and psychosocial outcomes controlling for preadolescent risk factors in a male cohort. Soc Psychiatry Psychiatr Epidemiol. 2023 Oct;58(10):1469–81. doi: https://doi.org/10.1007/s00127-023-02454-8 DOI: https://doi.org/10.1007/s00127-023-02454-8
  63. Davis CN, Gizer IR, Agrawal A, Statham DJ, Heath AC, Martin NG, et al. Genetic and shared environmental factors explain the association between adolescent polysubstance use and high school noncompletion. Psychol Addict Behav. 2024 Feb;38(1):114–23. doi: https://doi.org/10.1037/adb0000915 DOI: https://doi.org/10.1037/adb0000915
  64. Davis CN, Gizer IR, Lynskey MT, Statham DJ, Heath AC, Martin NG, et al. Adolescent substance use and high school noncompletion: exploring the nature of the relationship using a discordant twin design. Addiction. 2023 Jan;118(1):167–76. doi: https://doi.org/10.1111/add.15996 DOI: https://doi.org/10.1111/add.15996
  65. Schneider KE, Brighthaupt SC, Winiker AK, Johnson RM, Musci RJ, Linton SL. Characterizing profiles of polysubstance use among high school students in Baltimore, Maryland: A latent class analysis. Drug Alcohol Depend. 2020 Jun;211:108019. doi: https://doi.org/10.1016/j.drugalcdep.2020.108019 DOI: https://doi.org/10.1016/j.drugalcdep.2020.108019
  66. Connor JP, Leung J, Chan GC, Stjepanović D. Seeking order in patterns of polysubstance use. Curr Opin Psychiatry. 2023 Jul;36(4):263–8. doi: https://doi.org/10.1097/YCO.0000000000000881 DOI: https://doi.org/10.1097/YCO.0000000000000881
  67. Davis CN, Slutske WS, Martin NG, Agrawal A, Lynskey MT. Identifying subtypes of cannabis users based on simultaneous polysubstance use. Drug Alcohol Depend. 2019 Dec;205:107696. doi: https://doi.org/10.1016/j.drugalcdep.2019.107696 DOI: https://doi.org/10.1016/j.drugalcdep.2019.107696
  68. Mefodeva V, Carlyle M, Walter Z, Chan G, Hides L. Polysubstance use in young people accessing residential and day-treatment services for substance use: substance use profiles, psychiatric comorbidity and treatment completion. Addiction. 2022 Dec;117(12):3110–20. doi: https://doi.org/10.1111/add.16008 DOI: https://doi.org/10.1111/add.16008
  69. Zentralplus. Medikamenten- und Drogenmissbrauch aufgedeckt. Drogen aus dem Darknet: Luzerner Polizei ermittelt gegen 50 Personen2019 14.2.24; 2024.
  70. Zentralplus. Luzerner Drogenring: Zwei Jugendliche sind an Überdosis gestorben2020 14.2.24; 2024. Available from: https://www.zentralplus.ch/gesellschaft/luzerner-drogenring-zwei-jugendliche-sind-an-ueberdosis-gestorben-1817387/
  71. Berger L. Wieder sind zwei Jugendliche aus Luzern am Drogenkonsum gestorben2020 14.2.24; 2024.
  72. Prinz P. Betroffener Teenager: «Wir haben uns richtig abgeschossen»2019 14.2.24.
  73. Babst A. «Ich wollte immer high werden, richtig ausgeknockt» – wie 50 Luzerner Jugendliche einen Drogenring gründeten2020 14.2.24.
  74. Nittnaus M. Xanax-Missbrauch an Schulen: Jetzt muss der Bundesrat handeln2020 14.2.24.
  75. Messmer M. Wird in der Prävention vor den falschen Drogen gewarnt? Innert zweier Jahre starben in Luzern mindestens vier Jugendliche an Drogencocktails. Jetzt wird das Thema politisch.2020 14.2.24.
  76. Riklin F. Wodka und Benzos zur Selbstmedikation. SonntagsZeitung. 2024 4.2.24.
  77. Bachmann A, Galgano L, Guillaume M. Jugendliche mit Medikamenten- und Mischkonsum: Situations- und Bedarfsanalyse, Empfehlungen - Synthesebericht. Bern: Infodrog; 2022. https://www.infodrog.ch/files/content/ff-de/Bericht_Jugendliche%20Mischkonsum%20Situationsanalsyse%20und%20Empfehlungen.pdf
  78. Bachmann A, Wettstein H. Medikamenten(misch)konsum – gefährliche Praxis bei Jugendlichen und jungen Erwachsenen. pharmaJournal. 2023;10(10):4.
  79. Steinhoff A, Bechtiger L, Ribeaud D, Eisner MP, Quednow BB, Shanahan L. Polysubstance Use in Early Adulthood: Patterns and Developmental Precursors in an Urban Cohort. Front Behav Neurosci. 2022 Jan;15:797473. doi: https://doi.org/10.3389/fnbeh.2021.797473 DOI: https://doi.org/10.3389/fnbeh.2021.797473
  80. Rieder VS. Motive für Mischkonsum. Olten: Fachhochschule Nordwestschweiz FHNW; 2022. https://irf.fhnw.ch/entities/publication/8d518836-8a6f-443f-9100-5b9b61b34442
  81. Zai D. Drogen(misch-)konsum von Jugendlichen im Kanton Schwyz: Ergebnisbericht Jugendbefragung. In: Prävention gs-FfGu, editor. Schwyz2024.
  82. Jordan MD, Balsiger N, Schmidhauser V. Consommation de substances psychoactives chez les 11 à 15 ans en Suisse–Situation en 2022 et évolution dans le temps. 2023. DOI: https://doi.org/10.58758/hbsc.fs01
  83. Storni M, Lieberherr R, Kaeser M, Schneider S. Schweizerische Gesundheitsbefragung 2022. Neuchatel: Bundesamt für Statistik, BFS; 2024.
  84. Sucht Schweiz. Schweizer Suchtpanorama 2023. Lausanne: Sucht Schweiz; 2023. https://www.suchtschweiz.ch/press/das-schweizer-suchtpanorama-2023/
  85. Kroll T, Neri M. Designs for Mixed Methods Research. In: Andrew S, Halcomb EJ, editors. Mixed Methods Research for Nursing and the Health Sciences. Wiley Online Library; 2009. pp. 31–49. 10.1002/9781444316490.ch3 DOI: https://doi.org/10.1002/9781444316490.ch3
  86. Hanson WE, Creswell JW, Clark VL, Petska KS, Creswell JD. Mixed methods research designs in counseling psychology. J Couns Psychol. 2005;52(2):224–35. doi: https://doi.org/10.1037/0022-0167.52.2.224 DOI: https://doi.org/10.1037/0022-0167.52.2.224
  87. Collins KM, Onwuegbuzie AJ, Jiao QG. Prevalence of mixed-methods sampling designs in social science research. Eval Res Educ. 2006;19(2):83–101. doi: https://doi.org/10.2167/eri421.0 DOI: https://doi.org/10.2167/eri421.0
  88. Castro FG, Kellison JG, Boyd SJ, Kopak A. A methodology for conducting integrative mixed methods research and data analyses. J Mixed Methods Res. 2010 Sep;4(4):342–60. doi: https://doi.org/10.1177/1558689810382916 DOI: https://doi.org/10.1177/1558689810382916
  89. Creswell JW, Clark VL. Designing and conducting mixed methods research. Sage publications; 2017.
  90. Adams WC. Conducting semi‐structured interviews. Handbook of practical program evaluation. 2015:492-505. doi: https://doi.org/10.1002/9781119171386.ch19 DOI: https://doi.org/10.1002/9781119171386.ch19
  91. Auderset S. Feinheit-Bericht zeigt: Google behindert Suchtprävention2023 17.2.24. Available from: https://feinheit.ch/blog/feinheit-bericht-zeigt-google-behindert-suchtpraevention/
  92. Guest G, MacQueen KM, Namey EE. Applied thematic analysis. Thousand Oaks (CA): Sage Publications; 2011. DOI: https://doi.org/10.4135/9781483384436
  93. Gunn RL, Aston ER, Metrik J. Patterns of cannabis and alcohol co-use: substitution versus complementary effects. Alcohol Res. 2022 Feb;42(1):04.
  94. Lee CM, Calhoun BH, Abdallah DA, Blayney JA, Schultz NR, Brunner M, et al. Simultaneous alcohol and marijuana use among young adults: A scoping review of prevalence, patterns, psychosocial correlates, and consequences. Alcohol Res. 2022 Apr;42(1):08. doi: https://doi.org/10.35946/arcr.v42.1.08 DOI: https://doi.org/10.35946/arcr.v42.1.08
  95. Thompson K, Holley M, Sturgess C, Leadbeater B. Co-Use of Alcohol and Cannabis: Longitudinal Associations with Mental Health Outcomes in Young Adulthood. Int J Environ Res Public Health. 2021 Mar;18(7):3652. doi: https://doi.org/10.3390/ijerph18073652 DOI: https://doi.org/10.3390/ijerph18073652
  96. Turner S, Mota N, Bolton J, Sareen J. Self-medication with alcohol or drugs for mood and anxiety disorders: A narrative review of the epidemiological literature. Depress Anxiety. 2018 Sep;35(9):851–60. doi: https://doi.org/10.1002/da.22771 DOI: https://doi.org/10.1002/da.22771
  97. Boileau-Falardeau M, Contreras G, Gariépy G, Laprise C. Patterns and motivations of polysubstance use: a rapid review of the qualitative evidence. Health Promot Chronic Dis Prev Can. 2022 Feb;42(2):47–59. doi: https://doi.org/10.24095/hpcdp.42.2.01 DOI: https://doi.org/10.24095/hpcdp.42.2.01

Most read articles by the same author(s)